Navigation Links
Argon Medical Devices and Rex Medical Announce Exclusive License and Distribution Agreement for the 'Cleaner(TM)' Rotational Thrombectomy System

ATHENS, Texas, March 10 /PRNewswire/ -- Argon Medical Devices, Inc. announced today that it has entered into a definitive licensing agreement with privately held Rex Medical, LP ("Rex Medical") for exclusive rights to market and distribute the Cleaner™ Rotational Thrombectomy System in the United States, European Union and Canada. Cleaner is a medical device designed for the mechanical declotting of occluded native vessel dialysis fistulae and synthetic dialysis access grafts.

Argon and Rex Medical will be exhibiting at the 34th Annual Meeting of the Society of Interventional

Radiology (SIR) to be held in Tampa, FL from March 14-17, 2008.

"We are excited to partner with Rex Medical on this innovative technology. Preserving dialysis access is one of the most challenging therapeutic issues within the vascular access arena. The launch of Cleaner will provide a fast, effective method for declotting occluded vessels and grafts," said George Leondis, President of Argon Medical. "This is a significant step forward in Argon's strategy to provide unique solutions to the interventional space, and we are confident this 'best in class' product will quickly become a leading technology in this fast-growing market segment."

About the Cleaner™ Rotational Thrombectomy System

Cleaner™ technology is an ergonomically designed, percutaneous 6Fr catheter based system (single piece construction) that is compatible with a 6Fr introducer sheath. A disposable, battery operated hand held drive unit is attached to a wire and rotates at a low speed (4000 RPM). The distal, sinuous shaped tip of the wire facilitates atraumatic mechanical declotting of occluded native vessel fistulae and synthetic dialysis access grafts. The outer catheter distal tip and sinuous wire segment are both radiopaque for fluoroscopic visualization.

According to the company, Cleaner™ technology provides the physician base with superior trackability and steerability. This quiet and easy to use system has the ability to effectively operate, negotiate and macerate thrombus around the graft apex and opposing sheath.

There are over 500,000 patients currently undergoing treatment in the U.S. for End-Stage Renal Disease (ESRD). In addition, over 300,000 procedures are being performed annually in the U.S. to repair and clear thrombosed hemodialysis access grafts and fistulae. It is estimated that the dialysis patient population will continue to grow at a rate exceeding 6% annually.

About Argon

Argon Medical Devices, Inc. based in Athens, TX, is a privately-held global medical device company which manufactures and markets solutions for cardiovascular procedures. It is a subsidiary of ACI Holdings, a portfolio company of Roundtable Healthcare Partners

About Roundtable

RoundTable Healthcare Partners, based in Lake Forest, IL, is an operating-oriented private equity firm focused exclusively on the health-care industry. The partners of RoundTable have significant experience in managing, operating, acquiring and financing multibillion-dollar diversified health-care companies. RoundTable partners with companies that can benefit from its extensive industry relationships and proven operating and transaction expertise.

About Rex Medical, LP

Rex Medical, LP, based in Conshohocken, PA, is a privately held medical device company specializing in the development, manufacturing and marketing of minimally invasive medical devices targeted towards the cardiovascular, venous access, endosurgery and oncology markets.

SOURCE Argon Medical Devices, Inc.

Back to top



SOURCE Argon Medical Devices, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Argonauta Communications Certified as Women-Owned Business by the Womens Business Enterprise National Council (WBENC)
2. Argonauta Assist(TM)ance: Argonauta Communications Strives to Enhance Site-Based Recruitment Efforts
3. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
4. You May Have a Thyroid Problem and Not Know It - Particularly If Youre Over 60, Says a New Harvard Medical School Report
5. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
6. Globus Medical Raises $110 Million in Series E Financing Round
7. Quark Pharmaceuticals Appoints New Chief Medical Officer
8. Boston University Biomedical Engineers Find Chink in Bacterias Armor
9. Rochester Medical Anti-Infection Foley Catheter Demonstrates Effectiveness in Randomized Trial
10. Rockwell Medical Technologies, Inc. Begins Patient Enrollment for its SFP Dose-Ranging Study
11. Flexible Medical Systems Raises $1.2M Seed Investment for Initial Human Trials
Post Your Comments:
(Date:6/23/2016)... 23, 2016 Capricor Therapeutics, ... a biotechnology company focused on the discovery, development ... patient enrollment in its ongoing randomized HOPE-Duchenne clinical ... 50% of its 24-patient target. Capricor expects the ... quarter of 2016, and to report top line ...
(Date:6/23/2016)... -- , , , WHEN: , ... , , , LOCATION: , , , Online, with free ... EXPERT PANELISTS:  , , , Frost & Sullivan,s Global Vice President ... Industry Analyst, Divyaa Ravishankar and Unmesh Lal, Program Manager , ... is witnessing an exceptional era. Several new demand spaces, such as ...
(Date:6/23/2016)... , June 23, 2016 ... Oticon , industry leaders in advanced ... launch of Oticon Opn ™, the world,s first ... of possibilities for IoT devices.      (Photo: ... Oticon introduces a number of ,world firsts,: ...
Breaking Medicine Technology:
(Date:6/25/2016)... , ... June 25, 2016 , ... ... and non-athletes recover from injury. Recently, he has implemented orthobiologic procedures as a ... area —Johnson is one of the first doctors to perform the treatment. Orthobiologics ...
(Date:6/25/2016)... ... 2016 , ... Conventional wisdom preaches the benefits of moderation, whether it’s a ... the bar too high can result in disappointment, perhaps even self-loathing. However, those who ... , Research from reveals that behind the tendency to set ...
(Date:6/24/2016)... Michigan (PRWEB) , ... June 24, 2016 , ... Those ... deal with these feelings, many turn to unhealthy avenues, such as drug or alcohol ... of Marne, Michigan, has released tools for healthy coping following a traumatic event. , ...
(Date:6/24/2016)... ... , ... Marcy was in a crisis. Her son James, eight, was out of control. Prone ... physically. , “When something upset him, he couldn’t control his emotions,” remembers Marcy. “If ... at my other children and say he was going to kill them. If we ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Global law firm ... 2016 Legal Elite. The attorneys chosen by their peers for this recognition are considered ... Seven Greenberg Traurig Shareholders received special honors as members of this year’s Legal Elite ...
Breaking Medicine News(10 mins):